Improving the safety and experience of transitions from hospital to home: a cluster randomised controlled feasibility trial of the 'Your Care Needs You' intervention versus usual care.
Care of older people
Cluster randomised controlled trial
Complex intervention
Feasibility trial
Hospital discharge
Patient experience
Patient safety
Transitions of care
Journal
Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536
Informations de publication
Date de publication:
01 Oct 2022
01 Oct 2022
Historique:
received:
20
06
2022
accepted:
19
09
2022
entrez:
1
10
2022
pubmed:
2
10
2022
medline:
2
10
2022
Statut:
epublish
Résumé
The 'Your Care Needs You' (YCNY) intervention aims to increase the safety and experience of transitions for older people through greater patient involvement during the hospital stay. A cluster randomised controlled feasibility trial was conducted on NHS inpatient wards (clusters) where ≥ 40% of patients were routinely ≥ 75 years. Wards were randomised to YCNY or usual care using an unequal allocation ratio (3:2). We aimed to recruit up to 20 patients per ward. Follow-up included routine data collection and questionnaires at 5-, 30-, and 90-days post-discharge. Eligible patients were ≥ 75 years, discharged home, stayed overnight on participating wards, and could read and understand English. The trial assessed the feasibility of delivering YCNY and the trial methodology through recruitment rates, outcome completion rates, and a qualitative evaluation. The accuracy of using routinely coded data for the primary outcome in the definitive trial was assessed by extracting discharge information for up to ten nonindividual consenting patients per ward. Ten wards were randomised (6 intervention, 4 control). One ward withdrew, and two wards were unable to deliver the intervention. Seven-hundred twenty-one patients were successfully screened, and 161 were recruited (95 intervention, 66 control). The patient post-discharge attrition rate was 17.4% (n = 28). Primary outcome data were gathered for 91.9% of participants with 75.2% and 59.0% providing secondary outcome data at 5 and 30 days post-discharge respectively. Item completion within questionnaires was generally high. Post-discharge follow-up was terminated early due to the COVID-19 pandemic affecting 90-day response rates (16.8%). Data from 88 nonindividual consenting patients identified an error rate of 15% when using routinely coded data for the primary outcome. No unexpected serious adverse events were identified. Most patients viewed YCNY favourably. Staff agreed with it in principle, but ward pressures and organisational contexts hampered implementation. There was a need to sustain engagement, provide clarity on roles and responsibilities, and account for fluctuations in patients' health, capacity, and preferences. If implementation challenges can be overcome, YCNY represents a step towards involving older people as partners in their care to improve the safety and experience of their transitions from hospital to home. ISRCTN: 51154948.
Sections du résumé
BACKGROUND
BACKGROUND
The 'Your Care Needs You' (YCNY) intervention aims to increase the safety and experience of transitions for older people through greater patient involvement during the hospital stay.
METHODS
METHODS
A cluster randomised controlled feasibility trial was conducted on NHS inpatient wards (clusters) where ≥ 40% of patients were routinely ≥ 75 years. Wards were randomised to YCNY or usual care using an unequal allocation ratio (3:2). We aimed to recruit up to 20 patients per ward. Follow-up included routine data collection and questionnaires at 5-, 30-, and 90-days post-discharge. Eligible patients were ≥ 75 years, discharged home, stayed overnight on participating wards, and could read and understand English. The trial assessed the feasibility of delivering YCNY and the trial methodology through recruitment rates, outcome completion rates, and a qualitative evaluation. The accuracy of using routinely coded data for the primary outcome in the definitive trial was assessed by extracting discharge information for up to ten nonindividual consenting patients per ward.
RESULTS
RESULTS
Ten wards were randomised (6 intervention, 4 control). One ward withdrew, and two wards were unable to deliver the intervention. Seven-hundred twenty-one patients were successfully screened, and 161 were recruited (95 intervention, 66 control). The patient post-discharge attrition rate was 17.4% (n = 28). Primary outcome data were gathered for 91.9% of participants with 75.2% and 59.0% providing secondary outcome data at 5 and 30 days post-discharge respectively. Item completion within questionnaires was generally high. Post-discharge follow-up was terminated early due to the COVID-19 pandemic affecting 90-day response rates (16.8%). Data from 88 nonindividual consenting patients identified an error rate of 15% when using routinely coded data for the primary outcome. No unexpected serious adverse events were identified. Most patients viewed YCNY favourably. Staff agreed with it in principle, but ward pressures and organisational contexts hampered implementation. There was a need to sustain engagement, provide clarity on roles and responsibilities, and account for fluctuations in patients' health, capacity, and preferences.
CONCLUSIONS
CONCLUSIONS
If implementation challenges can be overcome, YCNY represents a step towards involving older people as partners in their care to improve the safety and experience of their transitions from hospital to home.
TRIAL REGISTRATION
BACKGROUND
ISRCTN: 51154948.
Identifiants
pubmed: 36183129
doi: 10.1186/s40814-022-01180-3
pii: 10.1186/s40814-022-01180-3
pmc: PMC9525931
doi:
Types de publication
Journal Article
Langues
eng
Pagination
222Subventions
Organisme : Programme Grants for Applied Research
ID : RP-PG-1214-20017
Informations de copyright
© 2022. The Author(s).
Références
Annu Rev Public Health. 2015 Mar 18;36:307-23
pubmed: 25581153
BMC Med Res Methodol. 2012 Mar 20;12:32
pubmed: 22433024
BMC Med Res Methodol. 2019 Aug 2;19(1):169
pubmed: 31375082
Qual Life Res. 2013 Sep;22(7):1717-27
pubmed: 23184421
BMJ Qual Saf. 2017 Aug;26(8):622-631
pubmed: 28159854
BMJ. 2004 Jun 26;328(7455):1561-3
pubmed: 15217878
BMJ Qual Saf. 2019 Jan;28(1):3-6
pubmed: 29764929
Int Disabil Stud. 1988;10(2):61-3
pubmed: 3403500
BMJ Qual Saf. 2018 Apr;27(4):331-332
pubmed: 29183917
BMC Health Serv Res. 2020 Aug 24;20(1):780
pubmed: 32831038
Hong Kong Med J. 2010 Oct;16(5):383-9
pubmed: 20890004
J Am Geriatr Soc. 2017 Jun;65(6):1119-1125
pubmed: 28369722
Health Expect. 2022 Sep 3;:
pubmed: 36056639
Int J Qual Health Care. 2017 Apr 01;29(2):256-261
pubmed: 28453826
BMC Health Serv Res. 2019 Jul 19;19(1):505
pubmed: 31324171
J Eval Clin Pract. 2012 Dec;18(6):1211-8
pubmed: 22070191
BMJ Qual Saf. 2018 Jul;27(7):539-546
pubmed: 29146681
Health Expect. 2019 Feb;22(1):102-113
pubmed: 30345726
BMC Med Res Methodol. 2010 Jan 06;10:1
pubmed: 20053272
Int J Qual Health Care. 2016 Jun;28(3):384-90
pubmed: 27224995
Med Care. 2008 Mar;46(3):317-22
pubmed: 18388847
BMJ. 2016 Oct 24;355:i5239
pubmed: 27777223
Appl Ergon. 2020 May;85:103060
pubmed: 32174348
J Clin Epidemiol. 2005 Jun;58(6):595-602
pubmed: 15878473
Pilot Feasibility Stud. 2020 Sep 02;6:123
pubmed: 32905158
BMC Health Serv Res. 2019 Mar 12;19(1):158
pubmed: 30866908
Glob Qual Nurs Res. 2017 Mar 01;4:2333393617696687
pubmed: 28462358
BMJ. 2020 Dec 31;371:m4973
pubmed: 33384281
Res Social Adm Pharm. 2021 Feb;17(2):273-291
pubmed: 32299684
Health Expect. 2019 Oct;22(5):883-893
pubmed: 31301114
Qual Saf Health Care. 2008 Apr;17(2):90-6
pubmed: 18385400
J Eval Clin Pract. 2004 May;10(2):307-12
pubmed: 15189396
CMAJ. 2011 Apr 19;183(7):E391-402
pubmed: 21444623
JAMA Intern Med. 2016 Apr;176(4):484-93
pubmed: 26954564
Qual Health Res. 2017 Jan;27(1):24-36
pubmed: 27469975
Health Expect. 2021 Dec;24(6):1936-1947
pubmed: 34599866
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
BMJ Qual Saf. 2016 Aug;25(8):565-8
pubmed: 27334867
Ann Intern Med. 2003 Feb 4;138(3):161-7
pubmed: 12558354
JAMA Intern Med. 2014 Jul;174(7):1095-107
pubmed: 24820131